Dr Andrea Henden

Dr Andrea Henden is a clinician scientist with expertise in haematology, bone marrow transplantation, and immunotherapy. Their research focuses on improving outcomes for patients with blood cancers, including developing innovative CAR T cell therapies. Dr Henden is also investigating the potential of faecal microbiota transplants (FMT) to treat severe Graft-versus-Host-Disease (GVHD) in blood cancer patients. This groundbreaking research aims to harness the benefits of a healthy gut microbiome to improve patients' immune response and offer a safer, more effective treatment option.

Dr Henden's work combines clinical research with translational and basic science, reflecting a commitment to bridging the gap between laboratory discoveries and real-world patient care. Their ultimate goal is to translate scientific advancements into improved treatments and better outcomes for individuals facing challenging haematological conditions.